Cargando…

miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review

Pancreatic ductal adenocarcinoma (PDAC), a rare but lethal tumor, is difficult to diagnose without performing an invasive procedure. miRNAs are known to be deregulated in PDAC patients, and recent studies have shown that they can be used as diagnostic and prognostic of the disease. The detection of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alemar, Bárbara, Gregório, Cleandra, Ashton-Prolla, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677802/ https://www.ncbi.nlm.nih.gov/pubmed/26688661 http://dx.doi.org/10.4137/BMI.S27679

Ejemplares similares

Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Su, Qiang, et al.
Publicado: (2018)

Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma
por: Suzuki, Rei, et al.
Publicado: (2017)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
por: Ren, Le, et al.
Publicado: (2018)

Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Impact
por: Gregório, Cleandra, et al.
Publicado: (2020)

Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2021)

Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma
por: Dobre, Maria, et al.
Publicado: (2021)

Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma
por: Liu, Tiantian, et al.
Publicado: (2023)

An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
por: Makler, Amy, et al.
Publicado: (2022)

Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Guo, Shiwei, et al.
Publicado: (2021)

Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma
por: Supadmanaba, I Gede Putu, et al.
Publicado: (2021)

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions
por: Prinz, Christian, et al.
Publicado: (2022)

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma
por: Vahabi, Mahrou, et al.
Publicado: (2023)

Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma
por: Wang, Cheng, et al.
Publicado: (2021)

Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
por: Macedo, Gabriel S., et al.
Publicado: (2019)

Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions
por: Gnoni, Antonio, et al.
Publicado: (2013)

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2017)

Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2018)

Differential impact of the ERBB receptors EGFR and ERBB2 on the initiation of precursor lesions of pancreatic ductal adenocarcinoma
por: Meyers, Nora, et al.
Publicado: (2020)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma
por: Song, Jukun, et al.
Publicado: (2018)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma
por: Vezakis, Ioannis, et al.
Publicado: (2023)

MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2015)

Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer
por: Wu, Jing, et al.
Publicado: (2020)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
por: Wani, Javaid Ahmad, et al.
Publicado: (2022)

Diagnostic and prognostic potential clustered miRNAs in bladder cancer
por: Ware, Akshay Pramod, et al.
Publicado: (2022)

Construction of HCC-targeting artificial miRNAs using natural miRNA precursors
por: HUANG, XIAOMING, et al.
Publicado: (2013)

KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
por: Yu, Shuang-Ni, et al.
Publicado: (2016)

Global profiling of miRNAs and the hairpin precursors: insights into miRNA processing and novel miRNA discovery
por: Li, Na, et al.
Publicado: (2013)

Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
por: Li, Qing, et al.
Publicado: (2016)

Advances in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Premalignant Pancreatic Lesions
por: Yamada, Reiko, et al.
Publicado: (2023)

Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis
por: Hu, Liang-Hao, et al.
Publicado: (2015)

A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile
por: Cote, Gregory A, et al.
Publicado: (2014)

Prognostic Value of VEGF in Human Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
por: Wang, Lai Mun, et al.
Publicado: (2015)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
por: Wang, Yizhi, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease
por: Kruger, Deirdré, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r2v4g4kf20kgtbmamd1tof4iou